Burzynski Research Institute, Inc. (BZYR)
OTCMKTS · Delayed Price · Currency is USD
0.0203
-0.0047 (-18.80%)
Apr 15, 2026, 4:00 PM EST
BZYR Market Cap
BZYR has a market cap or net worth of $2.67 million as of April 16, 2026. Its market cap has decreased by -59.40% in one year.
Market Cap
2.67M
Enterprise Value
2.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since April 28, 1997, BZYR's market cap has decreased from 16.41M to 2.67M, a decrease of -83.74%. That is a compound annual growth rate of -6.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 2.67M | 6.28% |
| Dec 29, 2025 | 2.51M | -38.39% |
| Dec 31, 2024 | 4.07M | -29.55% |
| Dec 29, 2023 | 5.78M | 70.28% |
| Dec 23, 2022 | 3.40M | 115.33% |
| Dec 31, 2021 | 1.58M | -33.33% |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mosaic ImmunoEngineering | 5.03M |
| Bioxytran | 4.95M |
| Biomind Labs | 4.34M |
| AccuStem Sciences | 4.26M |
| GPL Holdings | 4.17M |
| Vaccinex | 3.43M |
| Galera Therapeutics | 3.13M |
| CASI Pharmaceuticals | 3.08M |